Utility of contrast-enhanced harmonic EUS for diagnosis of portal vein invasion by pancreatic cancer
- PMID: 35848657
- PMCID: PMC9688135
- DOI: 10.4103/EUS-D-21-00185
Utility of contrast-enhanced harmonic EUS for diagnosis of portal vein invasion by pancreatic cancer
Abstract
Background: The value of contrast-enhanced harmonic EUS (CH-EUS) for diagnosis of portal vein invasion in patients with pancreatic cancer was evaluated.
Patients and methods: This single-center, retrospective study included consecutive patients with pancreatic cancer who underwent both surgical resection after preoperative EUS, CH-EUS, and contrast-enhanced computed tomography (CE-CT) examinations between April 2015 and August 2017. CH-EUS evaluation was performed during the late phase. Portal vein invasion on EUS and CH-EUS was defined as no continuity in the line of the vessel wall. Definition of portal vein invasion on CE-CT was based on the Loyer's criteria. The accuracy of three modalities for diagnosis of invasion into the portal vein was compared using the McNemar's test.
Results: Eighty-eight patients (mean age: 71.0 years, ratio of male to female: 48:40) were eligible. Postoperative pathological results were as follows: seven cases of portal vein invasion; 81 cases without. Diagnostic accuracy of EUS, CH-EUS, and CE-CT for diagnosing invasion into the portal vein was 72.7%, 93.2%, and 81.8%, respectively. The differences between CH-EUS and CE-CT (P = 0.0094) and CH-EUS and EUS (P = 0.0022) were significant. EUS and CE-CT were comparable.
Conclusion: CH-EUS is useful for diagnosis of portal vein invasion by pancreatic cancer.
Keywords: Loyer's Criteria; contrast-enhanced computed tomography; contrast-enhanced harmonic EUS; pancreatic cancer; portal vein invasion.
Conflict of interest statement
None
Figures




Similar articles
-
Utility of contrast-enhanced harmonic endoscopic ultrasonography for T-staging of patients with extrahepatic bile duct cancer.Surg Endosc. 2022 May;36(5):3254-3260. doi: 10.1007/s00464-021-08637-1. Epub 2021 Aug 30. Surg Endosc. 2022. PMID: 34462868
-
Value of contrast-enhanced harmonic endoscopic ultrasound for diagnosing hepatic metastases of pancreatic cancer: A prospective study.J Gastroenterol Hepatol. 2021 Dec;36(12):3402-3409. doi: 10.1111/jgh.15661. Epub 2021 Aug 31. J Gastroenterol Hepatol. 2021. PMID: 34397113
-
Contrast-enhanced harmonic EUS with novel ultrasonographic contrast (Sonazoid) in the preoperative T-staging for pancreaticobiliary malignancies.Scand J Gastroenterol. 2010 Jun;45(6):732-8. doi: 10.3109/00365521003690269. Scand J Gastroenterol. 2010. PMID: 20205504
-
Contrast-enhanced harmonic endoscopic ultrasonography in gallbladder cancer and pancreatic cancer.Fukushima J Med Sci. 2017 Aug 9;63(2):39-45. doi: 10.5387/fms.2017-04. Epub 2017 Jul 5. Fukushima J Med Sci. 2017. PMID: 28680009 Free PMC article. Review.
-
Value of contrast-enhanced harmonic endoscopic ultrasonography with enhancement pattern for diagnosis of pancreatic cancer: A meta-analysis.Dig Endosc. 2019 Mar;31(2):125-133. doi: 10.1111/den.13290. Epub 2019 Jan 15. Dig Endosc. 2019. PMID: 30338569
Cited by
-
Endoscopic Ultrasound and Intraductal Ultrasound in the Diagnosis of Biliary Tract Diseases: A Narrative Review.Diagnostics (Basel). 2024 Sep 20;14(18):2086. doi: 10.3390/diagnostics14182086. Diagnostics (Basel). 2024. PMID: 39335765 Free PMC article. Review.
-
Role of Endoscopic Ultrasound in Diagnosis of Pancreatic Ductal Adenocarcinoma.Diagnostics (Basel). 2023 Dec 28;14(1):78. doi: 10.3390/diagnostics14010078. Diagnostics (Basel). 2023. PMID: 38201387 Free PMC article. Review.
-
Endoscopic Ultrasound-Guided Pancreatic Tissue Sampling: Lesion Assessment, Needles, and Techniques.Medicina (Kaunas). 2024 Dec 7;60(12):2021. doi: 10.3390/medicina60122021. Medicina (Kaunas). 2024. PMID: 39768901 Free PMC article. Review.
-
Endoscopy's Evolving Role in Locally Advanced and Borderline Resectable Pancreatic Cancer.Ann Surg Oncol. 2024 Oct;31(10):7086-7087. doi: 10.1245/s10434-024-15727-6. Epub 2024 Jul 5. Ann Surg Oncol. 2024. PMID: 38969852 No abstract available.
-
CHST12: a potential prognostic biomarker related to the immunotherapy response in pancreatic adenocarcinoma.Front Endocrinol (Lausanne). 2024 Jan 25;14:1226547. doi: 10.3389/fendo.2023.1226547. eCollection 2023. Front Endocrinol (Lausanne). 2024. PMID: 38333724 Free PMC article.
References
-
- Freeny PC, Traverso LW, Ryan JA. Diagnosis and staging of pancreatic adenocarcinoma with dynamic computed tomography. Am J Surg. 1993;165:600–6. - PubMed
-
- Laghi A, Iannaccone R, Catalano C, et al. Multislice spiral computed tomography in diagnosis and staging of pancreatic carcinoma: Preliminary experience. Dig Liver Dis. 2002;34:732–8. - PubMed
-
- Catalano C, Laghi A, Fraioli F, et al. Pancreatic carcinoma: The role of high-resolution multislice spiral CT in the diagnosis and assessment of resectability. Eur Radiol. 2003;13:149–56. - PubMed
-
- Treadwell JR, Zafar HM, Mitchell MD, et al. Imaging tests for the diagnosis and staging of pancreatic adenocarcinoma: A meta-analysis. Pancreas. 2016;45:789–95. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous